earnings
confidence high
sentiment neutral
materiality 0.75
Natera Q1 revenue $194.1M (+27.5% YoY), raises 2022 guidance to $790-810M
Natera, Inc.
2022-Q1 EPS reported
-$1.45
revenue$194,133,000
- Product revenue $190M, up 57.8% YoY; processed 489,300 tests, up 40.5%.
- Net loss $138.6M or ($1.45) per share vs. ($0.74) a year ago.
- Raised 2022 revenue guidance from $770-790M to $790-810M.
- Board and executives elect to take 100% equity compensation for remainder of 2022.
- Signatera ADLT reimbursement increased to $3,920 per test effective April 2022.